Insider Activity of Kreitzer Anatol
According to the SEC Form 4 filings, Kreitzer Anatol, being in a position of
- Chief Discovery Officer at MapLight Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 12248 shares for $96,024,over all time since 2026-10-15, has bought 0 shares, and sold 12248 shares for $96,024.
Biography of Kreitzer Anatol
No biography is available at this moment.